申请人:Active Biotech AB
公开号:US20020173519A1
公开(公告)日:2002-11-21
Compounds of formula (I)
1
and tautomers thereof are effective for the treatment of mammals suffering from diseases resulting from autoimmunity and pathological inflammation.
化合物式(I)1及其互变异构体对于治疗患有自身免疫和病理性炎症引起的疾病的哺乳动物是有效的。